Answers are grounded in this paper and cite their sources.
Synbiotic BB12-MIX, composed of compound prebiotics MIX and Bifidobacterium animalis BB-12, effectively alleviated loperamide-induced constipation in mice and exhibited more pronounced beneficial effects than either MIX or BB12 administered alone. The synbiotic restored colonic goblet cell numbers and upregulated Muc2, reinforcing the mucus barrier and intestinal lubrication to reduce fecal transit resistance. Mechanistically, BB12-MIX repaired the colonic neuromuscular axis by restoring smooth muscle thickness, increasing enteric neuron density, upregulating Bdnf and Scf, and modulating contractility markers, thereby enhancing propulsive motility. Metabolomics revealed elevated tryptophan-derived neuroactive metabolites, including serotonin and tryptamine, as confirmed by restored enterochromaffin cells and increased serum 5-HT to stimulate intestinal motility. Additionally, microbiota analysis showed BB12-MIX suppressed aberrant Akkermansia muciniphila overgrowth while enriching beneficial commensals. qPCR confirmed that MIX significantly increased viable BB-12 counts in feces. Collectively, compound prebiotics MIX promoted BB12 intestinal proliferation, while the BB12-MIX combination improved mucus barrier function and intestinal peristalsis, thereby alleviating constipation.
No takes yet. Share an insight, caveat, or question.
Han et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: